Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brostallicin in Myxoid Liposarcoma
NCT00633165Phase 2Unknown
- Sponsor
- Systems Medicine
- Start
- Aug 2007
- Primary completion
- Oct 2008
- Modality
- DNA Intercalators/Alkylators, Recombinant Proteins and Enzymes, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brostallicin in myxoid liposarcoma (MLPS), sponsored by Systems Medicine. Status: unknown.
02
Drugs
brostallicin
03
Conditions
myxoid liposarcoma (MLPS)
Beyond the preview
Go deeper on NCT00633165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633165.